USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
17 - 20 Jun 2024 | Amsterdam

Decode, detect, & defy: Expectations for digital biomarkers

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Alexandra Gonçalves VP, Head of Digital HealthBristol Myers Squibb
Alexandra Gonçalves
VP, Head of Digital HealthBristol Myers Squibb
Manuel Marina Breysse Co-Founder & CEOIdoven
Manuel Marina Breysse
Co-Founder & CEOIdoven
Ryan Field CEOKernel
Ryan Field
CEOKernel

About this Session:

In the past, the idea that technology could offer earlier detection and prevention of diseases, unparalleled insights into diseases currently not tracked well with diagnostic tests, and improved patient engagement, safety and quality of care, would have been laughable.\r\nOn the face of it, digital biomarkers are the holy grail, beautifully blurring the patient-consumer boundary, and providing clinicians with previously inconceivable levels of monitoring and data, and patients a level of health autonomy never previously possible.\r\nBut there is no perfect fit. Lack of precision, gaps in both evidence requirements and economic models, and questions around data ownership abound. Can digital biomarkers rise up to the expectations?